Journals / Toraks Dergisi / 2002 / Cilt: 3 - Sayı: 3

Pulmonary function tests and inhalation perfusion scintigraphy findings in patients with type 2 diabetes mellitus

Tip 2 diabetes mellituslu hastalarda solunum fonksiyon testi ve inhalasyon perfüzyon sintigrafisi bulguları

Pages
257–265
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, mild changes were observed in pulmonary functions and inhalation perfusion scintigraphy considering the duration of DM, degree of metabolic control and pulmonary microangiopathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To evaluate changes in pulmonary functions in patients with Type 2 diabetes mellitus (DM), 25 diabetics [mean age 55.6±9.9 years (33-68 years), mean duration of diabetes 9.4±7.5 years (0-30 years), 20 women and 5 men] were studied.
📊
Key Findings & Data:The control group consisted of 10 healthy people mean age 46.8±10.4 years (33-65 years), (6 female, 4 male).
💡
Conclusion & Impact:In conclusion, mild changes were observed in pulmonary functions and inhalation perfusion scintigraphy considering the duration of DM, degree of metabolic control and pulmonary microangiopathy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Solunum fonksiyon testleri · Teknesyum Tc 99m pentetat · Radyonüklid görüntüleme

Abstract

To evaluate changes in pulmonary functions in patients with Type 2 diabetes mellitus (DM), 25 diabetics [mean age 55.6±9.9 years (33-68 years), mean duration of diabetes 9.4±7.5 years (0-30 years), 20 women and 5 men] were studied. The control group consisted of 10 healthy people mean age 46.8±10.4 years (33-65 years), (6 female, 4 male). Pulmonary function tests (PFT), arterial blood gas analysis (ABGA) were performed. Alveolary-capillary membrane permeability and regional distribution of ventilation were assessed with Tc-99m DTPA aerosol inhalation scintigraphy and perfusion scintigraphy was administered with Tc-99m MAA. PFTs and ABGA were found to be normal in diabetics. Patients with microangiopathy had higher HbA 1c and PaCO2 levels than those of patients without (p<0.05). Maximal inspiratory pressure was reduced in patients with microangiopathy (p<0.05). The patients who had HbA1c levels >8% with poor glycemic control had higher PaCO2 levels (p<0.05) and showed a mild reduction in diffusing capacity for carbon monoxide (DLCO) and DLCO % (p<0.05). Pulmonary epithelial permeability assessed with Tc-99m DTPA aerosol scintigraphy did not show a significant difference in patients with DM and the control group. The clearance rates of the 2 upper lobes were slower in diabetics and in the group with complications. Also the total lung clearance and the clearance of both lungs were longer in patients with complications, which was not statisticaly significant. Inhalation and perfusion scintigrams showed small, subsegmental or nonsegmental perfusion defects mostly in the lower lung lobes in five patients with diabetic microangiopathy. In conclusion, mild changes were observed in pulmonary functions and inhalation perfusion scintigraphy considering the duration of DM, degree of metabolic control and pulmonary microangiopathy.

Özet

Tip 2 diabetes mellitusu (DM) olan hastalarda solunum fonksiyonlarını değerlendirmek amacıyla çalışmamıza 25 tip 2 diyabetik hasta [yaş ortalaması 55.6±9.9 (33-68), ortalama diyabet süresi 9.4±7.5 yıl (0-30); 20 kadın, 5 erkek] ile 10 sağlıklı kişi [yaş ortalaması 46.8±10.4 (33-65); 6 kadın, 4 erkek] kontrol grubu olarak alındı. Olgulara solunum fonksiyon testleri (SFT), arter kan gazı analizi (AKGA), alveolo-kapiller membran permeabilitesi ve bölgesel ventilasyon dağılımını değerlendirmek amacıyla Tc-99m DTPA aerosol inhalasyonu ve Tc-99m MAA ile perfüzyon sintigrafisi uygulandı. Diyabetik olguların akciğer volümleri, akım hızları ve AKGA değerleri normal sınırlarda bulundu. Mikroanjiyopatisi olan olguların HbA1c ve PaCO2 değerleri, mikroanjiyopatisi olmayan gruba göre daha yüksek bulundu (p 80 dk); komplikasyonları olan olguların her 2 akciğer ve total akciğer klirenslerinde uzama olduğu gözlendi. Diyabetik olguların bölgesel ventilasyon ve perfüzyon dağılımının incelenmesinde, mikroanjiyopatisi olan beş olguda daha çok alt loblarda küçük subsegmenter ve nonsegmenter perfüzyon defektleri izlendi. Sonuç olarak, SFT'de ve akciğer inhalasyon perfüzyon sintigrafisinde diyabetin süresi, metabolik kontrolün derecesi ve pulmoner mikroanjiyopati ile ilişkili hafif düzeyde değişiklikler oluştuğu düşünüldü.

🔖

Cite This Article

ARI, G., İTİL, O., ÇÖMLEKÇİ, A., ÖZDOĞAN, Ö., DEĞİRMENCİ, B., YEŞİL, S., AKKOÇLU, A. (2002). Pulmonary function tests and inhalation perfusion scintigraphy findings in patients with type 2 diabetes mellitus. Toraks Dergisi, Cilt: 3 - Sayı: 3, 257–265. https://ajindex.com/articles/368006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Bağrıaçık N. Diabetes Mellitus tanım,tarihçe. İstanbul Üniversitesi Cerrahpafla Tıp Fakültesi Yayınları 1997;9
  2. Vracko R, Thorning D, Huang T.W. Basal lamina of alveolar epithelium and capillaries:quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 1979;120:973- 83
  3. Sandler M, Bunn AE, Stewart RI. Pulmonary function in young insulin- dependent diabetic subjects. Chest 1986; 90:670-75
  4. Kida K, Utsuyama M, Takizawa T, Thurlbeck WM. Changes in lung morphologic features and elasticity caused by streptozotocin-induced diabetes mellitus in growing rats. Am Rev Respir Dis 1983;128:125-31
  5. Sandler M. Is the lung a target organ in diabetes mellitus? Arch Intern Med 1990;150:1385-8
  6. Alavi A, Worsley D. Scintigraphic evaluation of pulmonary disease In Fishman’s Pulmonary Diseases and Disorders 1st volume, 3rd ed. Mc Graw-Hill Companies,International edition 1998; 528
  7. Caner B, Uğur Ö, Bayraktar M, et al. Impaired lung epithelial permeability in diabetics detected by technetium-99m-DTPA aerosol scintigraphy. J Nucl Med 1994;35:204-6
  8. Lange P, Groth S, Mortensen J, et al. Diabetes mellitus and ventilatory capacity:a five year follow-up study. Eur Respir J. 1990;3:288-92
  9. Turaçlar UT, Candan F, Sümer H. Tip 2 diyabetik hastalarda solunum fonksiyon testleri. Tüberküloz ve Toraks Dergisi 1999;47:54-7
  10. Shnapf BM. Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Respir Dis 1984;130:930-2
  11. Buckingham B, Perejda AJ, Sandborg C. Skin, joint and pulmonary changes in type 1 diabetes mellitus. AJDC 1986;140:420-3
  12. Primhak RA, Whincup G, Tsanakas JN, Milner RDG. Reduced vital capacity in insulin-dependent diabetes. Diabetes 1987;36:324-26
  13. Bell D, Collier A, Matthews DM, et al. Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes 1988;37:829-31
  14. Ramirez LC, Nogare AD, Hsia C. Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. The Am J of Med 1991;91:371-6
  15. Cavan DA, Parkes A, O’Donnell MJ. Letter to the editor. Respiratory Medicine 1991;85: 257-8
  16. Cooper BG, Taylor R, Alberti KGM, Gibson GJ. Lung function in patients with diabetes mellitus. Respiratory Medicine 1990;84:235-39
  17. Schnack C, Festa A, D’assie AS, et al. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to inticipient diabetic nephropathy. Nephron 1996;74:395-400
  18. Asanuma Y, Fuj